The findings, Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity, were reported in Scientific Reports.
Our partners will work directly with your insurance provider to help with the process of determining coverage for your GLP-1 medication, which is paid for separately from the LifeMD programs
Your overall health, consistency of treatment, the dosage and frequency of sessions, and lifestyle factors like sun exposure, diet, and smoking also play a role
We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) with GLP-1 Receptor Agonists (RAs) in patients with and without chronic kidney disease (CKD)
Variants in glutathione-related enzymes may indicate your inherited capacity for detoxification, supporting a more personalized conversation with your provider about supplementation strategy